- Introduction
- DISCLAIMER
- Motivation
- Leukemia
- GPT-3
- GETTING STARTED
- Contributing
- Versioning
- License
- Bugs/Issues
The GPT-3 Leukemia Information Assistant is an open-source proof of concept application developed using the OpenAI API beta. The project is a HIAS AI Agent meaning it can be connected to the HIAS Network and can provide user interfaces with on demand information about Leukemia.
This project is a proof of concept and has been designed to demonstrate a possible medical use case for GPT-3. It is currently against OpenAI's use case guidelines to create a production application that is intended to provide medical advice.
This project is not to be used to provide medical information in the real world.
The information provided by this project may not be factually correct.
The motivation for this project is to see how GPT-3 could be used as a potential medical information source for leukemia.
Leukemia is a blood cancer characterized by a rapid production of abnormal white blood cells called blasts. In 2020, almost 500,000 new patients were diagnosed with leukemia all over the world and approximately 312,000 individuals died with this disease. In the United States, there are over 60,000 new cases every year, and over 24,000 patients die from leukemia annually.
For more information about Leukemia please visit our Leukemia Information Page
GPT-3 (Generative Pre-trained Transformer 3) uses state of the deep learning to produce human-like text for natural language understanding applications. The language prediction model is exposed via the OpenAI API Beta, a new offering from OpenAI that allows developers to implement state of the art language predictions into their applications.
Thank you to OpenAI for providing early access to the beta making this project possible.
Ready to get started ? Head over to the Getting Started guide for instructions on how to download/install and setup the GPT-3 Leukemia Information Assistant.
Peter Moss Leukaemia MedTech Research CIC encourages and welcomes code contributions, bug fixes and enhancements from the Github community.
Please read the AI AGENT CONTRIBUTING guide for a full guide to contributing to our AI Agent projects. You will also find our code of conduct in the CODE OF CONDUCT document.
-
Adam Milton-Barker - Peter Moss Leukaemia MedTech Research CIC Founder & Managing Director.
-
Dr Rita Rb-Silva - Peter Moss Leukaemia MedTech Research CIC Medical Advisor (Hematology), Porto, Portugal
We use SemVer for versioning.
This project is licensed under the MIT License - see the LICENSE file for details.
We use the repo issues to track bugs and general requests related to using this project. See AI AGENT CONTRIBUTING guide for more info on how to submit bugs, feature requests and proposals.